Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity (Q44348810)

2 December 2017

Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity (English)

1 reference

2 December 2017

0 references

Mellon RD

1

1 reference

PubMed ID

9602057

2 December 2017

Bayer BM

series ordinal

2

1 reference

PubMed ID

9602057

2 December 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

2 December 2017

1 reference

2 December 2017

789

1 reference

2 December 2017

1

1 reference

2 December 2017

56-67

1 reference

Psychoneuroimmunology: interactions between the nervous system and the immune system

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

The inhibition of ornithine decarboxylase activity in developing rat tissues by central nervous system beta-endorphin is mediated by mu-opioid receptors, but not by delta- or epsilon-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Neuropeptide innervation of lymphoid organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Studies on the mechanism of stimulation of ACTH secretion with the aid of morphine as a blocking agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Pharmacological characterization of opioid receptors influencing the secretion of corticotrophin releasing factor in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Analgesia produced by centrally administered DAGO, DPDPE and U50488H in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Mu receptor binding of some commonly used opioids and their metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Selectivity of Ligands for Opioid Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Use of mu and delta opioid peptides of various selectivity gives further evidence of specific involvement of mu opioid receptors in supraspinal analgesia (tail-flick test).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Effects of acute and chronic administration of mu- and delta-opioid agonists on the hypothalamic-pituitary-adrenocortical (HPA) axis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Analogues of β-LPH61–64 posessing selective agonist activity at μ-opiate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Effect of Intraventricular β-Endorphin and Morphine on Hypothalamic-Pituitary-Adrenal Activity and the Release of Pituitary β-Endorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Effects of central administration of morphine on immune status in Lewis and Wistar rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Life events, depressive symptoms, and immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Stress-induced alterations of immunity in hypophysectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Stress-induced suppression of immunity in adrenalectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Ligand binding profiles of U-69, 593-sensitive and-insensitive sites in human cerebral cortex membranes: evidence of kappa opioid receptors heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Nor-binaltorphimine decreases deprivation and opioid-induced feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Pituitary-adrenal activation following intrahypothalamic microinjection of morphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Experimental basis for neural-immune interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

The contribution of intrinsic activity to the action of opioids in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Mechanisms of Glucocorticoid Action on Immune Processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Effects of opioids on the hypothalamo-pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Central kappa- and mu-opiate receptors mediate ACTH-release in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Bimorphinans as highly selective, potent kappa opioid receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Effects of centrally administered opioid agonists on macrophage nitric oxide production and splenic lymphocyte proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Involvement of brain opiate receptors in the immune-suppressive effect of morphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

The periaqueductal gray matter mediates opiate-induced immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

Characterization of [3H]naltrindole binding to delta opioid receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901529-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(97)01529-1

1 reference

2 December 2017

1 reference

PubMed ID

9602057